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Abstract 
 
Pistacia lentiscus fatty oil (PLFO) is a well known natural remedy in eastern Algeria folk medicine. It is widely 
used in the treatment of respiratory disorders and dermal burns. The present study has been carried out to investigate effects 
of this oil on fasting glucose and some functional parameters of the liver and kidney in white male New Zealand rabbits 
(Initial mean weight 1.95 Kg). PLFO was applied to tested rabbits (PLFO group) via rectal route, once daily 5-day per week, 
for six consecutive weeks at the dose of 1ml/Kg body weight. The same number of animals (n=6) was not treated and served 
as control (CRL group). The results showed that PLFO was tolerated by rectal route. No significant differences were 
observed in body weights of the two groups. Biochemical analysis showed that aspartate transaminase (AST) and alanine 
transaminase (ALT) were significantly decreased in blood plasma at (P< 0.05) and (P< 0.01) respectively in PLFO group 
(Mann-Whitney test). On the other hand, the fasting glucose level (GLU) was significantly increased (Mann-Whitney test, 
P< 0.05), while the rest of the tested parameters (Albumin, total proteins, creatinine, urea) was not significantly affected. 
However, these variations have not biologic signification toxicity. The study concludes that PLFO is tolerable via rectal 
route; it is safe with no adverse effect on liver functions and renal functions with possible anti-glycogenesis activity.  
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Introduction 
 
Pistacia lentiscus L. is an evergreen shrub or small tree growing to 1-8 m tall belonging to the Anacardiaceous 
family (Lauk et al., 1996). It appears in dry open woods and scrublands in the Mediterranean region, and in guarrigues, 
maquis on sandy soils and dry rocky slopes (Dogan et al., 2003). It is a traditional natural remedy that has been used by very 
ancient Mediterranean civilizations like Greeks and Egyptians (Pellecuer et al., 1980). All parts of these plant posses 
medicinal uses. The leaves are extensively used in folk medicine for the treatment of eczema, diarrhea, and throat infections, 
and as a potent antiulcer agent (Ali-Shtayeh et al., 1998). The aerial parts have been used in the treatment of hypertension and 
possess stimulant and diuretic properties (Bently and Trimen, 1980). The mastic gum has been used for the relief of upper 
abdominal discomfort, stomachaches, dyspepsia and peptic ulcer (Al-Habbal et al., 1984). The essential oil extracted from 
the aerial parts has been proven to exhibit antioxidant, anti-inflammatory, antimicrobial (Benhammou et al., 2008), antifungal 
(Duru et al., 2003; Kordali et al., 2003) and antiatherogenic activities (Dedoussis et al. 2004). However, medicinal virtues of 
the fatty fruit’s oil are particularly known in North Africa, in the eastern region of Algeria to Tunisia. The people of these 
regions have used this fruit’s oil externally to treat sore throats, locally to remedy burns and wounds and internally for 
respiratory allergies (Boukef and Souissi, 1982). Benhammou et al. (2008) reported that this fatty oil has good nutritive 
quality because of its content in unsaturated fatty acids (Oleic + linoleic = 73%) and saturated fatty acids (Palmitic + stearic = 
25.8%). We have demonstrated in a previous study the beneficial effect of this oil in healing process (Djerrou et al., 2010). 
In eastern Algeria, some families have inherited, from their ancestors, medication by this oil especially in respiratory 
disorders. These people use this oil at the dose of two teaspoons to two tablespoons per day according to age. Noting that the 
production of this vegetable oil and its use for therapeutic purposes are increasing in recent years. Despite this wide spread 
use, no scientific studies are available to ascertain the safety of this traditional remedy. Hence, the present study has been 
undertaken to investigate PLFO effects on fasting glucose and some functional parameters of the liver and kidney in rabbit 
model.   
 
 
Materials and Methods 
 
The present study was carried out at Department of Biology, University of Mentouri, Constantine, Algeria.  
 
Extraction of Pistacia lentiscus fatty oil  
 
Thirty kg of ripe fruits (black berries) of Pistacia lentiscus L. were collected in December 2009 in Skikda region, 
located in eastern Algeria. The oil was extracted from fruits in a traditional press and was stored in vials worm away from 
light until use. 
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Animals and husbandry 
 
Healthy rabbits (New-Zealand, white, male, 4 months old, initial mean weight 1.95 Kg) were purchased from a 
local supplier (Hama Bouziane, Constantine, Algeria) and used for this study. Animals were kept in individual standard 
cages. A temperature of 22 ± 2º C, 50 – 75% relative humidity and a 12 h light-dark cycle were maintained in all times of 
experiment. Food and water were provided ad libitum. Animals were acclimated for laboratory conditions for a period of 7 
days prior to initiation of the experiment.  
 
Experimental protocol and drug administration 
 
The study was carried out on 12 New Zealand (male, white, initial mean weight 1.95 Kg, age 16 wk) rabbits. After 
an acclimatization of 7 days in laboratory conditions, the rabbits were divided randomly into two groups of six each. Animals 
of first group were not treated and served as control (CRL group), the others served as tested group (PLFO group). In all 
animals for this group, PLFO was applied, once daily, 5-day per week, at the dose of 1 ml/Kg body weight, via rectal route 
for 6 consecutive weeks. The most important advantage suggested for the rectal administration is the possibility of avoiding 
the hepatic first-pass metabolism and the gastrointestinal tract (Choi et al., 1998; Khafagy, 2007). The choice of the dose of 
1ml/kg body weight per day was based on doses used in folk medicine, as described above, in humans by oral consumption. 
This dose is usually used in repeat dose oral toxicity study (Limit-test) adopted by OECD (2006). The experimental protocol 
was approved by the Ethical Committee of the Faculty of Sciences of Constantine University. 
  
Clinical alterations and determination of body weights 
 
Rabbits were clinically evaluated daily; the observation was carried on anal region and anal sphincter, clinical signs 
(e.g. sliding on the back-side, signs of pain) and feces (e.g. blood and mucus). Sacrifice of animals after administration 
period, necropsy and macroscopic examination of rectal mucosa (CPMP, 2001). The animals were weighted at the beginning 
of the experiment and repeated weekly until their sacrifice. 
 
Biochemical analysis 
 
At the end of experimentation, animals were fasted overnight, and blood samples were performed on heparinized 
tubes from marginal ear vein of rabbits. Plasma was obtained by blood centrifugation at 3000 rpm for 5 min and then stored 
at -20° C until used for analysis. The selected blood parameters were performed, in the Hormonal Chemistry Laboratory of 
Constantine, by a biochemical analyzer (Architect CI 8200) and included aspartate amino transferase (AST), alanine amino 
transferase (ALT), blood creatinine (CREA), fasting glucose (GLU), total proteins (TP), albumin (ALB) and urea. 
 
Statistical analysis 
 
Data obtained from body weight measurements were expressed as mean ± SD, the biochemical analyses were 
presented as median ± IQR (Inter quartile range). Parametric variables were analyzed by one-way ANOVA. Non parametric 
variables were analyzed with Mann-Whitney U test. All statistical tests were performed with SPSS 10.0 program. Differences 
between treated group and control were considered significant at P<0.05.  
 
 
 
 
Results 
 
During the experimentation period, no mortality was seen in the animals. All rabbits remained healthy and they 
were available for assessment.  
 
Clinical alterations and body weights  
 
All the animals (CRL group and PLFO group) were clinically normal throughout the experimental period. Only one 
rabbit from PLFO group, in the second week of experiment, had diarrhea for 3 days. Clinical observations of rectal mucosa 
showed a slight erythema from the second week until end of experiment. Administration of PLFO to rabbits daily for 6 weeks 
had no significantly effect on body weight (Fig. 1). The weight gains obtained after 52 days from the beginning of 
experiment were 990±72.5 g/rabbit in PLFO group and 923±141.5 g/rabbit for the untreated rabbits. 
 
 
Clinical chemistry 
 
Statistical analysis of clinical chemistry data was registered in table 1. Liver enzymes levels (median ± IQR, n = 6) 
were significantly reduced in rabbits treated by PLFO. Aspartate aminotransferase (AST) showed a significant decrease 
(Mann-Whitney test, P< 0.05) in PLFO group compared to control group. Similarly, alanine aminetransferase (ALT) was 
reduced significantly (Mann-Whitney test, P< 0.01) in tested rabbits compared to control animals (Fig. 2A). Plasmatic 
fasting glucose level (median ± IQR, n = 6) was significantly higher (Mann-Whitney test, P< 0.01) in PLFO group compared 
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to control group (Fig. 2B). In the other hand, creatinine was found to be slightly higher, but none significantly in PLFO 
group, than those detected in control. Urea was found to be slightly lower but none significantly in PLFO group than those 
detected in control (Fig. 2C and D). The results showed also that total proteins and albumin concentrations in PLFO group 
were very slightly lower but none significantly compared to control (Fig.  2E and F). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 1: Plasma chemistry values in New Zealand male rabbits treated for 6-weeks by PLFO and control group. 
 
Blood parameters Control (n=6) 
(median ± IQR) 
PLFO (n=6) 
(median ± IQR) 
U Z P 
AST (U/L) 
ALT (U/L) 
CREA (mg/L) 
GLU (g/L) 
TP (g/L) 
ALB (g/L) 
UREA (g/L) 
45 (28 – 80) 
69.5 (40 – 80) 
9.7   (8 – 11) 
0.82 (0.55 – 0.89) 
68 (56 – 74) 
17 (15 – 18) 
0.325 (0.21 – 0.38) 
24 (13 – 35) 
28,5 (20 –42) 
10.1 (9 – 16) 
0.995 (0.94 – 1.05)  
67.5 (56 – 71) 
16.5 (14 – 17) 
0.315 (0.26 – 0.45) 
33 
35 
27.5 
36 
22 
22.5 
21.5 
 
 2.40192 
2.72218 
1.52122 
2.88231 
0.640513 
0.720577 
0.560449 
0.01515152@ 
0.004329© 
0.1320346 
0.0021645© 
0.588744 
0.484848 
0.588744 
@ Significant at P<0.05(two-tailed test). 
© Significant  at P<0.01 (two-tailed test) 
 
 
 
 
Discussion 
 
In the present study, rabbits have not presented signs of toxicity in all the experimental period. The animals of 
PLFO group have exhibited a normal behavior in comparison to CRL group. Any macroscopically lesions were observed in 
rectal mucosa. No significant differences were observed in body weight gain of the two groups. In view of these partial 
results, we can assert that PLFO did not cause clinical alterations for rabbits during its application for 6 consecutive weeks. 
In several organs, cell damage is followed by released of a number of cytoplasmic enzymes to the blood, 
phenomena that provides the basis for clinical diagnosis (Sundberg et al., 1994). In our study, hepatic function was evaluated 
by measuring plasma ALT and AST activities, albumin and total proteins concentrations. Renal function was evaluated by 
measuring plasma creatinine and urea concentrations (Davis and Berdt, 1994; Finco, 1997; Correges et al., 1998). Regarding 
biochemical data, all biochemical blood parameters investigated in this study were within the physiological range as reported 
by Archetti et al. (2008). Additionally, our results showed a significant decrease of transaminases; AST and ALT 
concentrations were 1.8 and 2.4 times respectively lower than those observed in the control group. It is known that damage to 
the structural intergrity of liver is reflected by increase in the liver hepato-specific enzymes (ALP, ALT and AST) in the 
serum, because they are cytoplasmic in location and are released into circulation after cellular damage (Janbaz and Gilani, 
1995; Venkateswaran et al., 1995). These transaminases play important roles in amino acids metabolism and providing 
necessary intermediates in gluconeogenesis (Hanley et al., 1986). According to this, the significant decrease of plasma 
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Figure 1:  Trends in mean body weights of male New Zealand rabbits treated in 
PLFO and control group (CRL). 
doi: 10.4314/ajtcam.v8i5S.27
Djerrou et al.,  Afr J Tradit Complement Altern Med. (2011) 8(S):214-219 217
 
                      
       
                
                      
 
 
 
 
 
 
 
 
 
 
 
                                  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
B
©
B C
0
20
40
60
80
100
U
/L
 o
f p
la
sm
a
ALT
 CRL
 PLFO
D 
B C
6
8
10
12
14
16
18
m
g/
L 
of
 p
la
sm
a
CREA
 CRL
 PLFO
E
B C
0,10
0,15
0,20
0,25
0,30
0,35
0,40
0,45
0,50
0,55
G
/L
 o
f p
la
sm
a
UREA
 CRL
 PLFO
F
B C
50
55
60
65
70
75
80
P
la
sm
a 
pr
ot
ei
n 
co
nc
en
tr
at
io
n 
(g
/L
)
TP
 CRL
 PLFO
G
B C
13
14
15
16
17
18
19
g/
L 
of
 p
la
sm
a
ALB
 CRL
 PLFO
A 
 
B C
0
20
40
60
80
100
U
/L
 o
f p
la
sm
a
AST
 CRL
 PLFO
@
B C
0,5
0,6
0,7
0,8
0,9
1,0
1,1
G
lu
co
se
 le
ve
l (
g/
L)
GLU
 CRL
 PLFOC ℗ 
Figure 2: Comparison of some biochemical parameters in the plasma of rabbits from control group (CRL) and rabbits treated in 
Pistacia lentiscus fatty oil (PLFO) for 6 consecutive weeks. (A) Enzymatic activity of AST.  (B) Enzymatic activity of ALT. (C) 
Glucose level. (D) Creatinine concentration. (E) Urea concentration. (F) Total protein concentration. (G) Albumin concentration.  
Values are expressed as median ± IQR (n = 6). @ Significant at P < 0.05 (Mann-Whitney, Z=2.40192, P= 0.01515152), © 
Significant at P<0.01(Mann-Whitney, Z=2.72218, p=0.004329), ℗ Significant at P<0.01 (Mann-Whitney, Z=2.88231, 
p=0.0021645). 
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transaminases (ALT and AST) activities of treated rabbits could indicate an improvement in liver function due to a possible 
hepatoprotective activity of PLFO. This pharmacological property has been investigated in Pistacia lentiscus plant in earlier 
study. It has been reported by Janakat and Al-Merie (2002) that aqueous extract of P. lentiscus (both boiled and non-boiled) 
showed marked antihepatotoxic activity against CCL4 (Carbon tetrachloride) by reducing the activity of the three enzymes 
(ALP, ALT and AST) and the level of bilirubin. They concluded that P. lentiscus is effective in the treatment of hepatic 
jaundice in the rat.  
According to literature, the hepatoprotective medicinal preparations must: possess antioxidant properties; stabilize 
cell membranes; inhibit microsomal cytochrome P-450-dependent system activity, as the primary source of oxygen free 
radicals, and have anti-inflammatory properties (Lukivskaya et al. 2006). Its worth asking whether compounds of PLFO were 
implicated in the amelioration of liver functions. Preliminary studies indicated that this fatty oil contains two fractions: the 
unsaponifiable fraction presented mainly by tocopherols and phytosterols; the saponifiable fraction  which is rich in 
unsaturated fatty acids (UFA) and saturated fatty acids (SFA). Phytosterols have been found to exhibit anti-inflammatory and 
anti-oxidant activities (Moreno, 2003). Tayal et al. (2007) reported that alpha-tocopherol (Vitamin E) is a potent antioxidant 
that provides hepatoprotection by scavenging free radicals. Hernández et al. (2005) reported that treatment with a balanced 
diet rich in olive oil contributed to the recovery of the liver from hepatic steatosis, by decreasing activation of hepatic stellate 
cells by MUFAs, which are less susceptible to lipid peroxidation compared to PUFAs. Moreover, previous studies carried out 
in fibrotic rats showed that olive oil, in contrast to polyunsaturated oils, could protect against the development of fibrosis 
(Szende et al., 1994). In view of these cited studies, the variations of transaminases in PLFO group may be essentially due to 
tocopherols, phytosterols and unsaturated fatty acids compounds. 
Fasting glucose level was found to be increased (21.3%) in PLFO group compared to value of untreated rabbits. 
Values in the two groups were correspondent to standards. It is known that liver is the main organ of glycogen metabolism. 
The decrease of glycogen in liver is a common result of hepatic insufficiency after liver lesions caused by toxic compounds. 
This hepatic insufficiency can cause an increase of insulin in blood, and a consecutive reduction of the blood sugar content, 
which is consistent with glycogen/glucose level in liver (Wu et al., 2005). In our study, elevation of glucose level may be 
explained by an effect of PLFO on liver cell metabolism. This later may affect directly the synthesis, the storage and the 
decomposition of glycogen in liver.  In addition, this fatty oil was known for its antioxidant properties due to tocopherols and 
phytosterols. The inhibition of fatty acids oxidation can lead to a decrease in glycogenesis due to the inhibition of acetyl CoA 
(Golden and Kean, 1984).  
Regarding renal function, variations of creatinine and urea were found to be none significant between the two 
groups; consecutively renal function was not alliterated by PLFO treatments. Decreases in concentration of whole plasma 
proteins and albumin have been proposed as indicators of the alteration of protein synthesis (Kubena et al., 1993).  A drop in 
serum albumin level is usually the result of decreased protein synthesis by the liver or increased protein loss trough the gut of 
the kidney, other possible cause of decrease in albumin may include mal absorption (Orhue et al., 2005). In the present study, 
total proteins and albumin were reduced very slightly and none significantly in tested group. This is why we report that PLFO 
treatment had no significant impact on proteins and albumin concentrations.  
 
Conclusion 
 
Results from this study demonstrated that PLFO is well tolerated by rectal route. It is safe and no adverse effect on 
LFT and RFT was seen with possible anti-glycogenesis activity. 
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